Target Cancer with Anti-Angiogenesis

Use natural products that work on the same pathway of  “state of the art” anti-cancer drugs. 


At the top of the list, use compounds that stop new blood vessel formation (which is one of the ways cancer can spread.)

A comprehensive discussion of Dr. Folkman’s discovery of this cancer pathway is outlined in Appendix.

A listing of the natural compounds that also appear to block this growth (called anti-angiogenesis compounds) is below.  Also see

Here are some of the most powerful anti-angiogenesis naturals:

  1. Soy extract
  2. Artichoke
  3. Parsley
  4. Berries
  5. Soy
  6. Garlic
  7. Red grapes
  8. Brassica
  9. Citrus
  10. Lavender
  11. Green tea
  12. Glucosamine
  13. Turmeric
  14. Tea

Anti-Angiogenesis For Cancer Prevention and Treatment

We all have abnormal cancer cells in our bodies. Most of these micro-tumors are dormant.
Cancer can not grow larger than the size of the tip of a ball point pen without first developing a network of blood vessels.
If we can prevent abnormal cells from forming a network of blood vessels, we can render them harmless. Researchers are developing drugs designed to stop blood vessel growth (called angiogenesis). These drugs have had some success; however, they come with serious side effects.
Research has demonstrated that fruits, vegetables, mushrooms and some legumes have anti-angiogenesis compounds within them that may prove to be powerful cancer preventatives
The most powerful anti-angiogenesis foods are listed
Certain supplements may help to further concentrate food-based anti-angiogenensis compounds in the body

The Breakthrough Discovery

Back in the early nineteen sixties, a navy surgeon, by the name of Dr. Judah Folkman, happened upon a discovery that would revolutionize the way that we view cancer development in the human body. While testing the impact of preserved blood on fast growing tumor cells (a model used to mimic fast growing tissues of wounds) he noticed that cancer cells that would normally ravage the body of a living mouse, could only seem to grow to the size of the tip of a ball point pen in a Petri dish. He wondered why the same tumor cells didn’t replicate with the same level of aggression in a Petri dish as they did in a living creature. After all, he had taken great care to mimic the conditions of living tissue.

After dissecting the large tumors from the living creatures and comparing them to the tiny tumors from his Petri dish experiment, he noticed only one difference between the two tumors; the large tumors from the mice were filled with thousands of tiny networks of blood vessels while the tumor cells from the Petri dish experiment had no such blood supply. From this experiment, he hypothesized that the cancer cells could not develop into a large tumor mass unless and until it had developed a network of small blood vessels called capillaries to feed the cells.  This process of blood vessel development was named “angiogenesis”.  Said another way, if we could prevent cancer cells from developing a blood supply of their own, we could stop cancer growth in its tracks and even cause existing tumors to regress! Furthermore, if tumor cells could not develop a blood supply, they would not be able to metastasize.

Dr. Folkman’s hypothesis and experiment was met with ridicule and rejection from the medical community. In fact, after discussing with a colleague his worry that his research would get picked up and stolen by other researchers, his colleague replied, “You are totally protected against intellectual theft. Nobody will believe you!”

Dr. Folkman continued his experiments, and over the years, his hypothesis went on to be accepted.  His research led to the development of a new class of medication called anti-angiogenesis drugs. Since then, other anti-angiogenesis medications had come to market. Unfortunately, the clinical results were somewhat disappointing; some tumors responded quite well, while others responded partially or not at all.

William Li, founder of The Angiogenesis Foundation, a non-profit organization dedicated to the advancement of anti-angiogenesis therapies and lifestyles, believes that the main reason that the medications are not living up to their potential is because we are getting to people too late in the game, after the cancer is fully developed and situated.  He believes that if we can use non-toxic tactics to prevent the small cluster of cancerous cells from forming a blood flow in the first place, we can prevent tumors from developing altogether. This would be what Dr. Folkman calls, “Cancer without disease”.

Comments are closed.